Meta Launches Advanced Content Protection for Facebook Creators

by THEFUTURE.TEAM

November 18, 2025

Meta has introduced a sophisticated mobile tool designed to help creators protect their original reels from unauthorized use. This new feature, part of Meta’s ongoing commitment to support genuine content creators, automatically monitors for duplicate content across Facebook and Instagram, ensuring the rights of innovators are preserved.

How the System Works

The tool leverages the same matching technology as Meta’s Rights Manager to identify unauthorized reproductions of original reels. Creators receive notifications—integrated within their Feed, Professional Dashboard, and profile—when a match is detected. Upon alert, they have the option to block the reel’s visibility on both platforms, track its performance metrics, or add attribution links that reinforce their ownership.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Flexible Control and Attribution Options

In addition to blocking content, creators can opt to release their claim, thus keeping the reel visible. The tool also empowers creators who have authorized specific accounts to republish their content by enabling an “allow list”. This option prevents pre-approved duplicates from being flagged automatically. Moreover, creators can choose to add attribution links that label a reel as “original” while linking back to their profile or the original content, further strengthening their brand identity.

Program Eligibility and Rollout

Meta is initially providing this feature within its Facebook Content Monetization program and to creators who use Rights Manager. Eligible content creators can access the tool directly through their Professional Dashboard under the “Content Protection” section or by applying via Facebook’s website.

Balancing Protection and Fair Use

While the new system minimizes unauthorized distribution by lowering the visibility of flagged reels, Meta has made it clear that the tool is not intended to penalize accounts outright. Instead, it seeks to prevent misuse of creators’ content without enabling targeted abuse of the protection features. Creators who mistakenly file false reports could face restrictions on their own accounts, ensuring that the system is used responsibly.

A Forward-Looking Approach

Currently available on mobile, Meta is testing an expansion to include the Professional Dashboard on desktop, further boosting awareness and ease of management for content creators. This initiative is another strategic move by Meta, following its recent actions against impersonation and spam, to create a more secure and supportive ecosystem for original digital content.

By providing robust tools for copyright enforcement, Meta is reinforcing its commitment to safeguarding creativity, ultimately encouraging more creators to share their work with confidence.

The Future Forbes Realty Global Properties

Blood Proteins May Signal Prostate Cancer Risk More Than 15 Years Before Diagnosis

by THEFUTURE.TEAM

October 27, 2026

Distinctive proteins in men’s blood may offer clues to prostate cancer risk more than 15 years before a diagnosis, according to research from the University of Oxford. The findings could help scientists better understand why some prostate cancers become aggressive while others grow slowly and never cause serious harm.

Researchers analyzed blood samples from 2,555 men collected between 1992 and 2000. Of those participants, 982 were later diagnosed with prostate cancer; the remaining 1,573 served as a comparison group. The team measured more than 6,000 proteins in the samples, which had been collected years—and, in some cases, more than 15 years—before diagnosis.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Protein Patterns Were Linked To Different Risks

The analysis identified proteins associated with prostate cancer risk overall, as well as proteins linked specifically to more aggressive or fast-growing forms of the disease. Higher levels of certain immune-system proteins, including GZMK and ANXA2, were associated with a lower long-term risk.

“Finding proteins linked to known prostate cancer driver genes in blood collected years before diagnosis gives us new insights into the earliest stages of the disease,” said Karl Smith-Byrne, the study’s corresponding author at Oxford.

The results, published in European Urology, are significant because prostate cancer is not a single, uniform disease. Many tumors grow slowly and may never threaten a patient’s health, while others progress rapidly and can be life-threatening. A clearer way to distinguish between these outcomes could eventually help improve how clinicians assess risk.

Promising Findings, Not A Screening Test

The researchers stressed that the protein patterns are not ready to be used as a screening test. The associations need further validation before they can inform clinical decisions, and the study does not establish that the proteins cause cancer or that measuring them can predict an individual’s outcome.

“Ultimately, we hope this will help us understand the biology of aggressive prostate cancer and identify markers that could improve how we assess risk in the future,” said first author Zhe Huang, a postdoctoral epidemiologist at Oxford Population Health.

Research Could Point To New Prevention Strategies

Prostate cancer is the most commonly diagnosed cancer among men in the European Union and the second most common worldwide, after lung cancer. In the EU, approximately 330,000 cases are diagnosed and 75,000 men die from the disease each year.

By identifying biological signals that appear long before diagnosis, the research may help scientists investigate the pathways involved in aggressive disease. Smith-Byrne said that, alongside existing and future genetic evidence, the findings could help reveal pathways that might ultimately be targeted to prevent aggressive prostate cancer.

Breaking news